NCT00623207|CompletedPhase 3
Use of Atropine in Tredmill Stress Testing
Safety and Feasibility of Atropine Added During Treadmill Stress Testing in Patients With Chronotropic Incompetence or Poor Exercise Capacity.
Loading search results
Safety and Feasibility of Atropine Added During Treadmill Stress Testing in Patients With Chronotropic Incompetence or Poor Exercise Capacity.
Sponsor study identifier
interventional
103
1 country
1
Study Start
December 2007
Date type not reportedThis date has not been verified as actual or estimated.
Primary Completion
October 2009
Actual (reported)Study Completion
October 2009
Actual (reported)The aim of this study is to evaluate the Safety and feasibility of atropine added during treadmill stress testing in patients with chronotropic incompetence or poor exercise capacity. Our hypothesis is that we can increase heart rate by using atropin in these patients, so we will achieve more conclusive results.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
October 2009
Actual (reported)Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
December 2007
Date type not reportedThis date has not been verified as actual or estimated.
February 14, 2008
Actual (reported)February 25, 2008
Actual (reported)October 2009
Actual (reported)October 2009
Actual (reported)1- To characterize patients who can't achieve target heart rate at treadmill exercise test.2- To evaluate atropine added during treadmill stress testing in order to increase heart rate and achieave conclusive test.
1 yaer
Pateints who achieve target haert rate or conclusive test will not be given Atropine
Patients who won't achieve tarhet heart rate or conclusive results will be given Atropine
I.V Atropine 0.5mg up to 2 mg
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
Heart Institute, Ha'Emek Medical Center
Afula, Afula, 18100, Israel
103 participants (actual enrollment reported by the registry).
First Submitted
February 14, 2008
First Posted
February 25, 2008
Study Start
December 2007
Date type not reportedThis date has not been verified as actual or estimated.
Microdosed Atropine 0.1% and 0.01% Ophthalmic Solutions for Reduction of Pediatric Myopia Progression
Contact the study team to confirm eligibility.
Primary Completion
October 2009
Actual (reported)Study Completion
October 2009
Actual (reported)Last Updated
July 27, 2015
Record last verified: 2015-07
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: